30-day results from LRT 2.0 trial also show warfarin plus aspirin does not increase bleeding risk
Oral anticoagulation is associated with a lower incidence of leaflet thrombosis, but does not appear to be associated with increased bleeding, compared to aspirin alone at 30 days after transcatheter aortic valve replacement (TAVR) in low-surgical-risk patients, according to late-breaking trial results presented Tuesday at Cardiovascular Research Technologies (CRT) 2020 in National Harbor, Maryland.